InMode reported Q2 2026 GAAP revenues of $95.6 million, flat compared to Q2 2025, with margin compression evident in the earnings. The company's RF microneedling and radiofrequency platforms, once growth engines, are facing market saturation and competitive pressure.
Devices & Tech
InMode Q2 Flat Revenue, Margins Compress
Energy-device leader faces stagnation and pricing pressure as market matures and competition intensifies.
1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
InMode's flat revenue and margin compression signal market saturation and rising competitive pressure.
This is a warning signal for practices. InMode's installed base is mature; flat revenue suggests limited new unit placements and possible price competition from Cutera, Lumenis, and emerging ultrasound platforms like Sofwave. Margin compression typically precedes aggressive rebate or financing offers to move inventory. Practices with InMode equipment should monitor lease renewal terms closely—manufacturers often tighten rebates when top-line growth stalls. The flat revenue also reflects market consolidation: practices are consolidating device portfolios rather than adding new modalities, and InMode's premium pricing may be losing ground to lower-cost RF alternatives.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.